Related Experiment Video
Updated: Aug 18, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Immunologic staging of prostatic carcinoma: three years of experience
The Journal of Urology
|January 1, 1978
Abstract:
The immunological specificity of prostatic acid phosphatase has been demonstrated previously in the laboratory and used in a small number of patients. Our findings in 96 patients using gel immunodiffusion with an acid phosphatase antiserum in the study of bone marrow aspirates and lymph nodes are reported.

